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Background: Whilst exogenous carbohydrate oxidation (CHOEXO) is influenced by mono- and disaccharide
combinations, debate exists whether such beverages enhance fluid delivery and exercise performance. Therefore, this
study aimed to ascertain CHOEXO, fluid delivery and performance times of a commercially available maltodextrin/
fructose beverage in comparison to an isocaloric maltodextrin beverage and placebo.
Methods: Fourteen club level cyclists (age: 31.79 ± 10.02 years; height: 1.79 ± 0.06 m; weight: 73.69 ± 9.24 kg;
VO2max: 60.38 ± 9.36 mL · kg
·-1 min−1) performed three trials involving 2.5 hours continuous exercise at 50%
maximum power output (Wmax: 176.71 ± 25.92 W) followed by a 60 km cycling performance test. Throughout each
trial, athletes were randomly assigned, in a double-blind manner, either: (1) 1.1 g · min−1 maltodextrin + 0.6 g · min−1
fructose (MD + F), (2) 1.7 g · min−1 of maltodextrin (MD) or (3) flavoured water (P). In addition, the test beverage at
60 minutes contained 5.0 g of deuterium oxide (2H2O) to assess quantification of fluid delivery. Expired air samples were
analysed for CHOEXO according to the
13C/12C ratio method using gas chromatography continuous flow isotope
ratio mass spectrometry.
Results: Peak CHOEXO was significantly greater in the final 30 minutes of submaximal exercise with MD + F and
MD compared to P (1.45 ± 0.09 g · min−1, 1.07 ± 0.03 g · min−1and 0.00 ± 0.01 g · min−1 respectively, P < 0.0001),
and significantly greater for MD + F compared to MD (P = 0.005). The overall appearance of 2H2O in plasma was
significantly greater in both P and MD + F compared to MD (100.27 ± 3.57 ppm, 92.57 ± 2.94 ppm and 78.18 ± 4.07 ppm
respectively, P < 0.003). There was no significant difference in fluid delivery between P and MD + F (P = 0.078).
Performance times significantly improved with MD + F compared with both MD (by 7 min 22 s ± 1 min 56 s, or 7.2%)
and P (by 6 min 35 s ± 2 min 33 s, or 6.5%, P < 0.05) over 60 km.
Conclusions: A commercially available maltodextrin-fructose beverage improves CHOEXO and fluid delivery, which may
benefit individuals during sustained moderate intensity exercise. The greater CHOEXO observed when consuming a
maltodextrin-fructose beverage may support improved performance times.
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It has long been established that carbohydrate (CHO)
ingestion at frequent intervals, or late into submaximal
aerobic exercise can maintain plasma glucose concentra-
tions [1], and support performance through a number of
mechanisms including glycogen preservation, increased
total carbohydrate oxidation rates (CHOTOT), lowered
subjective perception of fatigue and prevention of acute
onset hypoglycaemia [1-3].
When exercise is of a prolonged nature (ie: >3 hours),
CHOTOT plays a significant role in sustaining power out-
put (particularly if the exercise is considered strenuous). It
is well established that exogenous carbohydrate oxidation
rates (CHOEXO) may be limited at 1.0 g.min
−1 when single
sugars eg: glucose, are consumed, due to saturation of
the intestinal sodium glucose cotransporter (SGLT1).
The resulting contribution from endogenous carbohy-
drate sources to maintain CHOTOT may therefore limit
performance.
However, combinations of glucose, fructose and su-
crose have yielded 20-55% greater CHOEXO than glucose
alone, through additional utilisation of a separate GLUT5
transport mechanism [4-8]. Whilst optimal CHO inges-
tion rates of 30–80 g.hr−1 have been recommended for
events lasting up to 2.5 hours, no differences in CHOEXO
have been observed between combined and single sugar
beverages at moderate CHO intakes (0.80 g.min−1 [9]).
Therefore, optimal CHOEXO are likely to coincide with
higher total ingestion rates of mixed sugar beverages.
Indeed, CHOEXO with combined glucose and fructose
beverages have been reported at 1.26 g.min−1 up to
1.75 g.min−1 with ingestion rates of 1.80 to 2.40 g.min−1
respectively [4]. Case study assessment of world class tri-
athletes in our laboratory have indicated high CHOEXO
values of >1.75 g.min−1 after 3 hours of competitive paced
cycling with sustained ingestion rates of 2.00 g.min−1
indicating potential training tolerance to carbohydrate
ingestion (unpublished observations). However, such
high intakes may not be practical, or indeed tolerable,
by club level and recreational athletes, and may exacerbate
gastrointestinal distress [10] which could be detrimental
to both sustained performance and beverage delivery.
The use of maltodextrin-fructose formulas have
been shown to elicit equally high CHOEXO [11], and
may maintain gastrointestinal comfort [12]. Whilst
the benefit of sports drinks on fluid delivery has been
contested [13], with higher carbohydrate delivery, there
is recent evidence to suggest that combined trans-
portable sugar beverages may enhance fluid delivery
[8,14-16], which may benefit the athlete when net
fluid loss may impede late stage exercise performance.
Less is known about commercially available sports
drinks [17], particularly maltodextrin-fructose formulas,
on fluid delivery.Of key interest is the effect of sports drinks on exer-
cise performance. The inclusion of CHO beverages has
been shown to improve exercise performance and time
to fatigue during relatively short laboratory [18-20] and
field based assessments [21]. More recently, studies have
demonstrated an effect of multiple transportable carbo-
hydrates on sustained time trial performance [22,23] and
power output [22,24]. However, this is not supported
elsewhere [25], especially when commercially available
carbohydrate beverages have been used [26].
With recent public interest in the accuracy of market-
ing claims, and whether commercially available sports
drinks are indeed beneficial for performance [27,28], we
were invited to undertake an independent assessment of
a commercial maltodextrin/ fructose beverage (MD + F:
Energy Source™, High 5 Ltd.) on total and exogenous
carbohydrate oxidation, and fluid delivery in comparison
to a maltodextrin only beverage (MD) and placebo (P).
A further aim was to assess the influence of the three
beverages on cycling performance following a period of
sustained steady state exercise. It was hypothesised that
the MD + F commercial formula would lead to greater
exogenous oxidation and fluid delivery rates, resulting in
a specific performance gains.
Materials and methods
Participants
Fourteen club level male cyclists were recruited for
participation following power calculation assessment
(G*Power3, Dusseldorf [29]). All participants had an
endurance training background of at least two years, and
did not suffer from diabetes or have known dysglycemia.
Before undertaking the study, participants were required
to provide written informed consent and satisfactorily
complete a health screen questionnaire. Additionally,
participants were excluded if consuming other nutri-
tional supplements. Ethical approval for the study was
provided by the University of Hertfordshire Life and
Medical Sciences Ethics Committee.
Procedures
Preliminary testing
At least one week prior to experimental trials, participants
completed an incremental exercise test to volitional ex-
haustion for assessment of maximal power output (Wmax)
and maximal oxygen consumption (VO2max). All testing
was undertaken in the Human Physiology Laboratory,
Division of Sport, Health and Exercise, University of
Hertfordshire. Upon reporting to the laboratory, the
participants’ nude body mass (Seca, model 780, Hamburg,
Germany) and height were recorded. Following this,
maximal tests were performed on a Computrainer
(RaceMate Inc, Seattle, USA) and related Coaching
Software program (Comp CS, RaceMate Inc, Seattle,
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dardised to the body mass and cycle of the participant.
Following a 10 minute standardised warm-up at 100 W,
an incremental step protocol was then undertaken, with
power output progressing by 30 W each 3 minutes until
volitional exhaustion. Participants were fitted with an
oro-nasal face mask (7920 series, Hans Rudolph Inc.,
Kansas City, USA) attached to a triple-V digital volume
transducer. Respiratory data was recorded throughout
exercise using a Metalyzer 3B system online automated
gas-analyser in conjunction with Metasoft version 3
software (Cortex Biophysik, Leipzig, Germany). Heart
rate (HR) was recorded continuously via radio-telemetry
(Polar Electro Oy, Kempele, Finland). Ratings of perceived
exertion (RPE) were collected in the final minute of
each stage, using the Borg 6–20 subjective exertion
scale [30]. The test concluded when participants reached
volitional exhaustion or were unable to maintain the
required power output.
Maximal power was calculated by adding the final
completed workload to the fraction of time spent in the
non-completed workload, multiplied by 30 W. Oxygen
consumption (VO2) was defined as maximal when two
of the following criteria were met: 1) a levelling off of
VO2 with increasing workload (increase of no more than
2 ml · kgˉ1 · minˉ1); 2) attainment of maximal predicted
heart rate (±10 beats.min−1); and 3) a respiratory ex-
change ratio (RER) of >1.05. The highest attained VO2,
maintained for 20 seconds, was determined to be the
VO2max. Participants also undertook a separate habitu-
ation trial for both steady state and performance condi-
tions. The characteristics of the participants are shown
in Table 1.
Experimental trials
All experimental trials were undertaken in the Human
Physiology Laboratory, Division of Sport, Health and
Exercise, University of Hertfordshire under controlled
conditions (temperature: 22.4 ± 0.9°C; barometric pres-
sure – range: 979–1023 mBar; and relative humidity –
range: 21–56%). No differences were reported between
trials (P > 0.05) for any of the environmental variables.
The study employed a randomised, placebo-controlled,
double-blind cross over design for beverage condition.
Participants were required to perform three exercise trials
separated by one week, each comprising a 2.5 hour cycle
at 50% Wmax (oxidation trial), followed by a 60 km cycling
test (performance trial). Trials were undertaken at the
same time of day to minimise the potential for diurnal
variance. Participants reported to the laboratory following
a 12 hour overnight fast. Upon arrival, nude body mass
was measured and participants rested for 5 minutes be-
fore baseline measurements (for expired air and blood
analytes) were undertaken. All trials were performed ona pre-calibrated Computrainer (RaceMate Inc, Seattle,
USA), as employed in preliminary testing.
Sub-maximal oxidation trial
Following a 10 minute warm up at 100 W, participants
began a 2.5 hour oxidation trial at 50% Wmax. Steady
state power output was based on individual quantifica-
tion of Wmax from pre-experimental assessment. Expired
air samples were collected via the Douglas bag method
at 30 and 60 minutes, and then 15 minute intervals
thereafter, and analysed for percentage O2 and CO2,
using a Servomex 1440 gas analyser (Servomex Group
Ltd, Crowborough, UK). Total Douglas bag volume was
measured using a dry gas meter (Harvard Apparatus,
Holliston, USA). Standardised measurements for minute
ventilation (VE, L.min
−1), oxygen uptake (VO2, L.min
−1),
carbon dioxide (VCO2, L.min
−1) and respiratory exchange
ratio (RER) were recorded at 0, 30 and 60 minutes, and
every 15 minutes thereafter during the oxidation trial.
In addition, immediately following each Douglas bag
collection, duplicate 10 ml expired air samples were ex-
tracted into vacuumed Exetainer tubes (Labco Ltd, High
Wycombe, UK) for the determination of expired gas
13C:12C ratio. Exetainer samples were analysed inde-
pendently (Iso-Analytical Ltd., Crewe, UK) for 13C:12C
ratio by gas chromatography continuous flow isotope
ratio mass spectrometry (GC-IRMS, Europa Scientific
20–20 IRMS). Stable isotope measurements and indirect
calorimetry were used to calculate rates of CHOEXO,
CHOTOT (total carbohydrate oxidation) and FATTOT
(total fat oxidation).
At rest, and at 15 minute intervals throughout the oxi-
dation trial, 30 μl of capillarised wholeblood was col-
lected in heparinised tubes and frozen at −8°C for
subsequent analysis of blood glucose using an Analox
micro-stat PGM7 (Analox Instruments Ltd, London,
UK). Telemetric HR was recorded at 15 minute intervals
throughout the oxidation trial. Ratings of perceived exer-
tion (RPETOTAL and RPELEGS) using the 6–20 and 0–10
Borg scales respectively were recorded every 30 minutes
during submaximal exercise. Participants also verbally
completed an adapted 14 point gastrointestinal (GI) symp-
tom assessment questionnaire [31] every 30 minutes,
grading the degree of subjective discomfort on a 0–10
visual analogue scale. Particular attention was given to
symptoms categorised as both ‘moderate’ (4–6) and
‘severe’ (7–10).
Beverage administration
In a double-blind random order manner, participants
were assigned the following beverages across trials:
maltodextrin only (MD), isoenergetic maltodextrin with
fructose (MD + F) or aspartame sweetened, citrus fla-
voured water (P). All CHO beverages were supplied by
Table 1 Summary of participant characteristics and pre-experimental data collection
Age (years) Height (m) Weight (kg) VO2max (L.min
-1) VO2max (ml.kg
-1.min-1) Wmax (watts) 50% Wmax (watts)
31.79 ± 10.02 1.79 ± 0.06 73.69 ± 9.24 4.40 ± 0.56 60.38 ± 9.36 352.64 ± 52.39 176.71 ± 25.92
Table 1 shows the key characteristics of all participants, including data for maximal power output from pre-experimental assessment. Values are presented as
mean ± SD; n = 14; VO2max, maximal oxygen uptake; Wmax, maximal power output.
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in opaque drinks bottles. The test beverages provided an
average CHO delivery rate of 1.7 g · min−1 for MD
(corn-derived glucose monohydrate), and 1.1 g · min−1
maltodextrin with 0.6 g · min−1 fructose for MD + F
(using corn-derived glucose monohydrate and crystalline
fructose, Energy Source™, High 5 Ltd.). This was based
on discussion with the manufacturer to provide a realis-
tic, but high ingestion rate (102 g total carbohydrate per
hour in line with high dosages recommended for longer
duration exercise).
Beverages were administered as controlled 270 ml
doses at the start of the oxidation trial and every 15 mi-
nutes (until completion of the performance trial), pro-
viding a fluid intake of 1.08 L · h−1. In terms of content,
the test beverages per 100 g comprised: i) for MD + F –
96.7 g of total carbohydrate (of which 59.7 g from malto-
dextrin, 31.5 g from fructose); 0.0 g of protein and fat;
and delivered 388 kcal; ii) for MD - 96.0 g of total carbo-
hydrate (of which 90.9 g from maltodextrin, 4.0 g from
fructose); 0.0 g of protein and fat; and delivered 384 kcal;
and P – 0.3 g of total carbohydrate (of which 0.3 g total
sugars); 0.2 g of protein and 0.0 g of fat; and delivered
10 kcal.
All CHO beverages contained 816 mg per 100 g
(~35.5 mmol.L−1) of sodium (as tri-sodium citrate and
sodium chloride). Corn-derived glucose monohydrate
and crystalline fructose were used due to their naturally
high 13C content, allowing for the quantification of
CHOEXO. The ingested glucose and fructose were subject
to elemental analyser-isotope ratio mass spectrometry
(EA-IRMS; Europa Scientific 20–20) for the determination
of 13C-enrichment (MD: −11.41 δ‰, MD+ F: −11.84 δ‰
vs. Pee Dee Bellemnitella (PDB)).
Assessment of fluid delivery
The quantification of plasma deuterium enrichment has
previously been validated for qualitative assessment of
fluid delivery [8,14]. Based on both sample size power
determination (G*Power 3, Dusseldorf ) and cost, it was
deemed that only 7 participants were required for as-
sessment of fluid delivery. Prior to the oxidation trial, an
intravenous 20 gauge cannula was inserted by a qualified
phlebotomist into an antecubital vein for 7 of the partic-
ipants, to allow repeated blood sampling. Sample lines
were kept patent after each blood collection with a 2 ml
isotonic saline flush (0.9% sodium chloride saline, Baxter,
Norfolk, UK).Participants received 5 g of deuterium oxide (2H2O,
Sigma Aldrich, Dorset, UK), included in the beverage
administered at 60 minutes, for assessment of fluid de-
livery. Blood samples were collected in 10 ml Vacutainer
tubes, containing sodium fluoride/K3EDTA as an anti-
coagulant (Beckton Dickinson, Plymouth, UK), at 15 minute
intervals from the 60 minute time point into the oxidation
trial. Blood samples were analyzed for plasma 2H2O
enrichment via equilibration (Europa 20–20 continuous-
flow isotope ratio mass spectrometry) by an independent
laboratory (Iso-Analytical Ltd., Crewe, UK). Indwelling
cannulas were removed at the end of the oxidation trial.
Performance trial
Upon completion of the oxidation trial, participants per-
formed a 60 km performance trial using the same Com-
putrainer (RaceMate Inc, Seattle, USA). This was based
on manufacturer recommendation to simulate durations
encountered during sportive level events. Treatment
beverages continued to be ingested every 15 minutes in
the same quantity as for the oxidation trial. Participants
were instructed to complete the 60 km cycle course in
the fastest possible time, and were given verbal encour-
agement throughout the test coinciding with beverage
administration.
Telemetric HR and capillarised wholebood (for glucose
analysis as previously described) were assessed at 15 mi-
nute intervals. In line with laboratory safety regulations,
participants were required to stop exercising if blood
glucose dropped below 2.5 mmol·L−1. Gastrointestinal
symptom assessment was undertaken every 30 minutes
as previously described. Speed (km.hr−1), power output
(W) and distance covered (km) were recorded during
the performance trial at 15 minute intervals, but with an
adapted monitor only permitting sight of distance cov-
ered. At the cessation of the test, participants cooled
down for 5 minutes at 100 W.
Trial control measures
All participants were required to maintain a food and
exercise diary for 7 days prior to the first exercise trial,
and maintain these patterns before each subsequent trial.
Participants were provided with a list of foods naturally
abundant in 13C (CHO derived from C4 plants, e.g.: corn
and sugar cane) and instructed to avoid them for the
7 days prior to the first exercise trial and for the dur-
ation of the experimental period to reduce background
13C from endogenous stores. Food lists also provided a
Figure 1 Assessment of test beverages on mean CHOTOT
oxidation rates between 60–150 minutes of the submaximal
exercise trial. Figure 1 demonstrates the influence of all test
beverages on mean total carbohydrate oxidation rates in the final
90 minutes of the oxidation trial. Data are presented as mean ± SE;
n = 14. P, Placebo; MD, maltodextrin beverage; MD + F, maltodextrin-
fructose beverage; CHOTOT, total carbohydrate oxidation rates.
*denotes significant difference (P < 0.001) to P.
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reduction in CHO intake. Additionally, to reduce back-
ground interference from 13C-enriched glycogen stores,
participants performed a 150–180 minute glycogen-
depleting ride 5 days before each trial. Previous studies
have employed similar interventions to limit the effects
of background 13C-levels [5,7,8]. Participants were asked
to refrain from caffeine, alcohol ingestion and intense
exercise for 24 hours before each trial.
Calculations
Total oxidation rates:
Rates of CHOTOT and FATTOT (g · min
−1) were calcu-
lated from absolute VO2 and VCO2 (L · min
−1) utilising
the following stoichiometric equations [32], with protein
oxidation during exercise assumed negligible:
CHOTOT ¼ 4:585 VCO2ð Þ‐3:226 VO2ð Þ
FATTOT ¼ 1:695 VO2ð Þ‐1:701 VCO2ð Þ
Exogenous carbohydrate oxidation rates:
The rate of CHOEXO (g · min
−1) was calculated using
the following formula [33]:
CHOEXO ¼ VCO2 : Exp‐ExpBKG
Ing‐ExpBKG
 
: 1
k
 
Where δExp is the 13C-enrichment of expired air
throughout the oxidation trial, δIng is the 13C-enrichment
of the CHO solution, ExpBKG is the
13C-enrichment of
expired air throughout the placebo trial (P) and k is
the CO2 produced via the oxidation of 1 g of glucose
(k = 0.7467 litres of CO2 per gram of glucose [8]).
The 13C-enrichment was expressed as δ‰ difference
between the 13C:12C ratio of the sample and a known
laboratory reference standard (PDB) according to the
following formula [34]:
δ13C ¼
13C
12C of sample
13C
12C of standard
 !
‐1
" #
:103
The rate of CHOENDO was calculated by subtracting
CHOEXO from CHOTOT. Substrate oxidation was calcu-
lated over the final 90 minutes of exercise (60–150 minutes)
due to the earlier capture of 13CO2 in the bicarbonate
(HCO3ˉ) pool. It has been reported that dilution in the
bicarbonate pool becomes negligible after 60 minutes
of exercise, when 100% of the 13CO2 from oxidation is
retrieved [8,35,36].
Carbohydrate oxidation efficiency:Estimation of carbohydrate oxidation efficiency was
determined using the following formula [7]:
CHOEXO efficiency ¼ 100 : CHOEXO
CHO ingestion rate
 
Statistical analyses:
Statistical analyses were performed using SPSS Statistics
for Windows version 19 (SPSS, Chicago, USA). A two-
way analysis of variance (ANOVA) with repeated mea-
sures design was used to assess for interaction effects
between conditions, trials and over time. Where appropri-
ate, a one-way ANOVA was used to assess for differences
for relevant experimental measures (e.g.: mean CHOEXO)
between trials only. Significant differences were assessed
with a student t-test with Bonferoni post hoc adjustments.
Where pertinent, pearson chi squared assessment was
undertaken (e.g.: gastrointestinal responses). An alpha
level of 0.05 was employed for assessment of statistical
significance. All data are reported as means ± SE.
Results
Submaximal oxidation trial
Total carbohydrate oxidation
Data for total carbohydrate oxidation rates are repre-
sented in Figures 1 and 2. During steady state aerobic
exercise performed at 50% Wmax, mean CHOTOT be-
tween 60–150 minutes were significantly different be-
tween treatment conditions (F = 20.601; P = 0.0001).
Mean CHOTOT were significantly greater for both
MD + F and MD compared with P throughout the last
90 minutes of steady state exercise (2.74 ± 0.07 g.min-1
for MD + F and 2.50 ± 0.11 g.min-1 for MD v 1.98 ±
0.12 g.min-1 for P respectively; P = 0.0001). Mean
Figure 2 Assessment of test beverages on mean CHOTOT oxidation rates at various timepoints during the submaximal exercise trial.
Figure 2 shows the difference between test beverages for total carbohydrate oxidation rates at specific 30 minute time periods in the final
90 minutes of the oxidation trial. Data are presented as mean ± SE; n = 14. P, Placebo; MD, maltodextrin beverage; MD + F, maltodextrin-fructose
beverage; CHOTOT, total carbohydrate oxidation rates. *denotes significant difference (P < 0.005) to P within timepoint assessment. † denotes
significant difference between MD and MD + F within timepoint assessment (P = 0.004).
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between MD + F and MD (P > 0.05).
When assessing specific intervals during the oxidation
trial, between 60–90 minutes and 90–120 minutes of
submaximal exercise performed at 50%Wmax, both
carbohydrate test beverages demonstrated higher mean
CHOTOT compared to P (P < 0.005). Whilst this observa-
tion continued in the last 30 minutes of the oxidation
trial, a significant difference was also found between
MD + F and MD between 120–150 minutes of the test
(2.81 ± 0.06 g.min-1 v 2.42 ± 0.10 g.min-1 respectively;
P = 0.004).
Exogenous carbohydrate oxidation
Data for CHOEXO are represented in Figure 3 and
Table 2. A significant interaction effect was found for
both time and beverage (F = 31.659; P = 0.0001). Whilst
no differences were observed between conditions at rest
(P > 0.05), both carbohydrate beverages displayed signifi-
cantly higher CHOEXO at all timepoints from 30 minutes
in comparison to P (P < 0.0001). Mean CHOEXO between
60–150 minutes was significantly different between test
conditions (F = 180.077; P = 0.0001). Both carbohydrate
beverages displayed significantly greater mean CHOEXO
compared with P (P = 0.0001). However, throughout the
final 90 minutes of steady state exercise, CHOEXO was
significantly higher with MD + F compared with MD
(1.27 ± 0.07 g.min-1 v 0.98 ± 0.04 g.min-1 respectively;
P = 0.019). When analysed for respective 30 minute time
periods, CHOEXO was significantly higher for MD + F
compared with MD between 90–120 minutes and
120–150 minutes only (P < 0.025). Peak CHOEXO was
significantly greater in the final 30 minutes of submax-
imal exercise with MD + F and MD compared to P(1.45 ± 0.09 g · min-1, 1.07 ± 0.03 g · min-1 and 0.00 ±
0.01 g · min-1 respectively, P < 0.0001), and significantly
greater for MD+ F compared to MD (P = 0.005).
Assessment of exogenous carbohydrate efficiency
(CHOEXO Eff%) was additionally undertaken across the
oxidation trial. Mean CHOEXO Eff% was significantly greater
with MD+ F and MD compared to P for all assessed time
periods (P < 0.0001). Additionally CHOEXO Eff% was sig-
nificantly greater with MD + F compared to MD overall
(74.7 ± 4.4% v 57.9 ± 2.1% respectively; P = 0.019), and at
respective assessed timepoints from 90 minutes (P < 0.025).
Endogenous carbohydrate oxidation
Data for mean CHOENDO are represented in Table 2. In
a similar pattern to mean CHOTOT, a significant inter-
action effect was found between treatment conditions
for mean CHOENDO between 60–150 minutes of the oxi-
dation trial (F = 13.822; P = 0.0001). Both MD + F and
MD conditions demonstrated lower mean CHOENDO
during the last 90 minutes of continuous exercise com-
pared to P (1.47 ± 0.07 g.min-1, 1.51 ± 0.10 g.min-1 and
1.97 ± 0.12 g.min-1 respectively; P < 0.004). Whilst mean
CHOENDO progressively declined for each averaged
30 minute period within treatment condition, the same
pattern was observed with both carbohydrate beverages
demonstrating significantly lower CHOENDO in compari-
son to P (P < 0.038). No differences were observed be-
tween MD + F and MD (P > 0.05).
Total fat oxidation
Data for mean FATTOT are shown in Table 2. Over the
final 90 minutes of the oxidation trial, mean FATTOT
was statistically different between conditions (F = 10.494;
P = 0.0001). Specifically, both carbohydrate beverages
Figure 3 Assessment of test beverages on exogenous CHO oxidation rates during the submaximal exercise trial. Figure 3 demonstrates
the time course effect of the test beverages on exogenous carbohydrate oxidation rates. Data are presented as mean ± SE; n = 14. P, Placebo; MD,
maltodextrin beverage; MD + F, maltodextrin-fructose beverage. *denotes an overall significant difference between MD + F and P (P = 0.0001).
† denotes an overall significant difference between MD and P (P = 0.0001). ‡denotes a significant difference between MD and MD + F at
specific timepoint (P < 0.008).
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P (P = 0.008). Whilst absolute values were lower for
MD + F in relation to MD, mean FATTOT was not
statistically different between carbohydrate beverages
(0.33 ± 0.04 g.min-1 for MD + F v 0.41 ± 0.05 g.min-1
for MD, P > 0.05) over the final 90 minutes of the
oxidation trial. The same observation was noted for allTable 2 Influence of test beverages on carbohydrate and fat
Overall
60-150 mins
CHOENDO P 1.97 ± 0.12
(g.min-1) MD 1.51 ± 0.10*
MD + F 1.47 ± 0.07*
CHOEXO P 0.00 ± 0.00
(g.min-1) MD 0.98 ± 0.04*
MD + F 1.27 ± 0.07*†
CHOEXO Eff P 0.1 ± 0.3
(%) MD 57.9 ± 2.1*
MD + F 74.7 ± 4.4*†
FATTOT P 0.59 ± 0.06
(g.min-1) MD 0.41 ± 0.05*
MD + F 0.33 ± 0.04*
Table 2 demonstrates the influence of the test beverages on endogenous and exog
trial. Data for carbohydrate oxidation efficiency are also shown to demonstrate the
averaged timepoints. Data are presented as mean ± SE; n = 14. P, Placebo; MD, maltod
carbohydrate oxidation; FATTOT, total fat oxidation; CHOEXO, exogenous carbohydrate o
difference (P < 0.038) to P within respective time period. † denotes a significant d30 minute intervals, with both carbohydrate beverages
demonstrating significantly lower mean FATTOT in
comparison to P only (P < 0.021).
Assessment of exercise intensity was deemed compar-
able during the oxidation trial, with no significant differ-
ences observed for mean absolute VO2 (L.min
-1) and
power output (W) between test conditions – see Table 3.oxidation rates during a submaximal exercise test
Respective time period assessed
60-90 mins 90-120 mins 120-150 mins
2.00 ± 0.12 1.92 ± 0.12 1.99 ± 0.12
1.66 ± 0.12* 1.52 ± 0.10* 1.35 ± 0.10*
1.62 ± 0.08* 1.41 ± 0.07* 1.36 ± 0.07*
−0.00 ± 0.01 0.02 ± 0.01 −0.00 ± 0.01
0.86 ± 0.04* 1.02 ± 0.04* 1.07 ± 0.03*
1.08 ± 0.07* 1.28 ± 0.07*† 1.45 ± 0.09*†
−0.1 ± 0.05 0.9 ± 0.8 −0.6 ± 0.8
50.5 ± 2.5* 60.1 ± 2.3* 63.0 ± 1.9*
63.5 ± 4.2* 75.5 ± 4.3*† 85.2 ± 5.0*†
0.58 ± 0.06 0.60 ± 0.06 0.58 ± 0.06
0.42 ± 0.05* 0.41 ± 0.05* 0.41 ± 0.05*
0.34 ± 0.03* 0.34 ± 0.04* 0.32 ± 0.04*
enous carbohydrate and fat oxidation rates during the submaximal exercise
progressive benefit of a combined sugar beverage overall and at 30 minute
extrin beverage; MD + F, maltodextrin-fructose beverage. CHOENDO, endogenous
xidation; CHOEXO Eff, carbohydrate oxidation efficiency *denotes a significant
ifference between MD and MD + F (P < 0.025) within respective time period.
Table 3 Assessment of oxygen uptake, power output,
mean heart rate, blood glucose and perceived exertion
during both the oxidation and performance trials
Oxidation trial Performance trial
VO2 (L.min
-1) P 2.65 ± 0.07 N/A
MD 2.69 ± 0.06 N/A
MD + F 2.70 ± 0.09 N/A
Power (W) P 176.3 ± 6.95 201.0 ± 22.4
MD 175.0 ± 6.67 197.6 ± 21.6
MD + F 174.4 ± 6.59 227.0 ± 23.2*
Heart rate (b.min-1) P 128.7 ± 4.7 149.0 ± 6.3
MD 132.4 ± 3.7 151.9 ± 6.3
MD + F 133.1 ± 4.4† 160.7 ± 5.0*
Blood glucose (mmol.L-1) P 3.90 ± 0.11 3.24 ± 0.25
MD 4.77 ± 0.12† 4.17 ± 0.22†
MD + F 4.97 ± 0.12† 4.18 ± 0.23†
RPETOTAL (6–20 scale) P 11.9 ± 0.6 15.6 ± 0.6
MD 12.2 ± 0.5 16.3 ± 0.5
MD + F 11.6 ± 0.6 16.4 ± 0.7
RPELEGS (0–10 scale) P 3.8 ± 0.4 7.1 ± 0.4
MD 4.2 ± 0.5 7.1 ± 0.3
MD + F 3.3 ± 0.4‡ 6.9 ± 0.6
Table 3 shows the average data for key physiological, power output and
subjective perception of exertion vaiables over both the oxidation and
performance trials. Data are presented as mean ± SE; (n = 14 for oxidation trial;
n = 6 for performance trial finishers). P, Placebo; MD, maltodextrin beverage;
MD + F, maltodextrin-fructose beverage; RPE, Rating of Perceived Exertion.
*denotes a significant difference to MD and P (P < 0.03). † denotes significant
difference to P (P < 0.05).‡ denotes a significant difference to MD (P = 0.021)
within trial only.
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Estimation of total fluid delivery, as assessed via plasma
2H2O enrichment is demonstrated in Figure 4. As the
deuterium oxide was provided within the 60 minute bev-
erage, this timepoint was employed for baseline compar-
isons. The increase in plasma 2H2O enrichment from
60 minutes served to quantify total fluid delivery both
within treatment condition and in comparison to P.
Plasma 2H2O enrichment increased in all conditions over
time (F = 55.491; P = 0.0001), demonstrating the greatest
increase in the P condition, with a peak of 101.67 ±
3.87 ppm by 120 minutes of the oxidation trial, and there-
after plateauing with an end value of 100.27 ± 3.56 ppm.
Plasma 2H2O enrichment was significantly lower in
the MD condition from 75 minutes in comparison to
P (P < 0.025), and from 90 minutes in comparison to
MD + F (P < 0.05). In contrast, values for plasma 2H2O
enrichment were statistically lower for MD + F compared
to P at the 90 and 105 minute timepoints only (P < 0.039).
The ingestion of MD+ F resulted in a peak plasma 2H2O
enrichment of 92.57 ± 2.94 ppm by the end of theoxidation trial, and was comparable to values obtained for
P (100.27 ± 3.56 ppm; P > 0.05).
60 km performance trial
Performance trial measures
Whilst all participants attempted the 60 km performance
trial, during the P condition, 8 athletes were unable to
finish demonstrating the exhaustive nature of the proto-
col. In contrast, all participants completed the perform-
ance trial whilst consuming both carbohydrate test
beverages. Statistical analysis was therefore carried out
on all finishers (n = 6) for comparison across trials. Rela-
tive differences in performance times between beverages
are shown in Figure 5. Additionally, inclusion of all
finishers (n = 14) for the two test beverages are shown
for interest.
Performance times were significantly faster with MD+ F
compared with MD and P (5722.8 ± 284.1 seconds v
6165.0 ± 257.9 seconds v 6117.5 ± 358.0 seconds re-
spectively; P < 0.05). In absolute terms, performance
times significantly improved with MD + F compared
with both MD (by 7 min 22 s ± 1 min 56 s, or 7.2%)
and P (by 6 min 35 s ± 2 min 33 s, or 6.5%, P < 0.05)
over 60 km. No difference was observed for perform-
ance times between MD and P (P > 0.05). The differ-
ence observed between MD + F and MD was further
noted when assessment of all 14 finishers was separ-
ately undertaken (5868.36 ± 151.31 seconds for MD + F
v 6217.14 ± 150.93 seconds for MD; P = 0.001).
In a similar manner, relative differences in mean power
output was significantly different for MD + F compared
to both MD and P for the performance trial (P < 0.03;
Figure 6). Mean power output was 14.9% greater with
MD + F compared to MD (227.0 ± 23.2 W v 197.6 ±
21.6 W, P = 0.029), and 13.0% greater with MD + F com-
pared to P (227.0 ± 23.2 W v 201.0 ± 22.4 W, P = 0.025).
No difference was observed for performance times be-
tween MD and P (P > 0.05). The difference observed
between MD + F and MD was further noted when as-
sessment of all 14 finishers was separately undertaken
(234.0 ± 12.0 W for MD + F v 204.3 ± 11.1 W for MD;
P = 0.001).
Other physiological and subjective measures during
both trials
Heart rate, perceived exertion, blood glucose and
gastrointestinal distress assessment
Data for mean heart rate (b.min-1), blood glucose and
subjective perceived exertion are shown in Table 3. Dur-
ing the oxidation trial, mean heart rate was marginally
lower with P (F = 4.059; P = 0.029), but only statistically
different to MD + F (P = 0.045). However, as no differ-
ences were observed for RPETOT, absolute VO2 or power
output (P > 0.05) compliance to the exercise intensity
Figure 4 Influence of beverage administration on plasma deuterium enrichment (ppm). Figure 4 shows the impact of the test beverages on
plasma deuterium enrichment, which was employed as a semi-quantitative method for assessing fluid delivery. Data are presented as mean ± SE;
n = 7. P, Placebo; MD, maltodextrin beverage; MD+ F, maltodextrin-fructose beverage. *denotes significant difference (P < 0.025) to P. † denotes
significant difference (P < 0.039) to P. ‡ denotes significant difference between MD and MD + F (P < 0.05).
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cantly greater with both test beverages in comparison
to P during the oxidation trial (F = 26.505; P = 0.0001),
although no differences existed between MD and MD+ F
(4.77 ± 0.12 mmol.L-1 and 4.97 ± 0.12 mmol.L-1 respect-
ively, P > 0.05). Mean subjective RPELEGS (using a 0–10
Borg Scale) was significantly lower for MD+ F compared
with MD (P = 0.021) over the course of the oxidation trial.
During the performance trial, greater participant effort
was demonstrated via increases in mean heart rate,
RPETOTAL and RPELEGS in comparison to the oxidationFigure 5 Relative differences in 60 km performance times between b
during the preloaded 60 km time trial when test beverages were compare
participants completed the test when consuming carbohydrate beverages.
beverage. Data are presented as mean ± SE; comparisons made for finisher
all finishers (end column: n = 14) *denotes significant difference between rtrial. However, as 8 athletes could not complete the
performance trial for P, comparisons were made for
finishers of all trials only. Mean heart rate was signifi-
cantly higher with MD + F (160.7 ± 5.0 b.min-1) com-
pared to both MD and P (151.9 ± 6.3 b.min-1 and 149.0
± 6.3 b.min-1 respectively, P < 0.03). Mean blood glu-
cose was similar between test beverages during the
performance trial (4.18 ± 0.23 mmol.L-1 for MD + F and
4.17 ± 0.22 mmol.L-1 for MD), with both being significantly
greater than P (3.24 ± 0.25 mmol.L-1) only (P < 0.05). No
differences were observed between test conditions foreverages. Figure 5 indicates the difference in performance times
d for all finishers. The final column is included to demonstrate that all
P, Placebo; MD, maltodextrin beverage; MD + F, maltodextrin-fructose
s of all trials (first three columns: n = 6) and between test beverages for
elative beverages (P < 0.05).
Figure 6 Relative differences in average power output between beverages during the performance trial. Figure 6 indicates the difference
in average power measured in watts, during the preloaded 60 km time trial when test beverages were compared for all finishers. The final column is
included to demonstrate that all participants completed the test when consuming carbohydrate beverages. P, Placebo; MD, maltodextrin beverage;
MD+ F, maltodextrin-fructose beverage. Data are presented as mean ± SE; comparisons made for finishers of all trials (first three columns: n = 6) and
between test beverages for all finishers (end column: n = 14) * denotes significant difference between relative beverages (P < 0.05).
Table 4 Influence of test beverages on overall
gastrointestinal distress responses
Symptom P MD MD+ F
Urge to urinate 33 (26.2)* 17 (13.5) 19 (15.1)
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(P > 0.05).
Overall responses to the gastrointestinal distress ques-
tionnaire are shown in Table 4. A higher number of
significantly positive responses were noted for MD.
Bloating and belching severity were considerably greater
with MD (22.2% and 19.0%) compared to MD+ F (<4.8%)
and P (<1.6%) respectively (P < 0.05). Whilst responses for
other symptoms were considered minor ie: <7% of all re-
sponses, it was noted that symptoms of nausea, stomach
problems, and urge to vomit or defecate were observed in
the MD trial.Bloating severity 2 (1.6) 28 (22.2)* 6 (4.8)
Belching severity 2 (1.6) 24 (19.0)* 5 (4.0)
Nausea 1 (0.8) 8 (6.3)* 0 (0.0)
Stomach problems 1 (0.8) 7 (5.6)* 0 (0.0)
Stomach cramps 0 (0.0) 1 (0.8) 0 (0.0)
Headaches 1 (0.8) 2 (1.6) 0 (0.0)
Intestinal cramps 0 (0.0) 0 (0.0) 0 (0.0)
Stomach burning 1 (0.8) 2 (1.6) 0 (0.0)
Flatulence severity 0 (0.0) 2 (1.6) 0 (0.0)
Left & right side aches 3 (2.4) 0 (0.0) 1 (0.8)
Dizziness 8 (6.3)* 1 (0.8) 2 (1.6)
Urge to defecate 0 (0.0) 4 (3.2)* 0 (0.0)
Urge to vomit 0 (0.0) 4 (3.2)* 0 (0.0)
Table 4 shows the overall data for responses to the gastrointestinal distress
questionnaire, with particular attention given to responses rated moderate to
severe. Data are presented as total number of responses (rated moderate to
severe) for both oxidation and performance trials. Numbers in brackets
represent data expressed as a percentage of maximum number of responses.
P, Placebo; MD, maltodextrin beverage; MD + F, maltodextrin-fructose beverage.
*denotes a significant difference to other test conditions (P < 0.05).Discussion
The aim of this study was to carry out an independent
assessment of a commercially available sports drink on
carbohydrate oxidation, fluid delivery and sustained per-
formance. Whilst previous research has indicated bene-
fits of consuming multiple transportable carbohydrates
[11,12,16,22], there is minimal research on commercial
formulas demonstrating such mechanisms in line with
performance gains. Additionally, there is continued
interest as to whether sports drinks are indeed beneficial
to recreational and club level athletes, with implications
that moderately higher dosing strategies may yield ef-
fective results for longer duration events. With current
dosage recommendations for events lasting longer than
2 hours being >90 g.hr-1 [4], we were asked to investi-
gate the potential influence of a commercial MD + F
beverage provided at a relatively high carbohydrate
delivery rate (102 g.hr-1) on club level athletes.The main finding from the study was that a commercial
MD+ F beverage significantly enhanced both CHOEXO
and fluid delivery during steady state exercise compared
to both MD and P. This resulted in an average higher
power output and time to complete the subsequent 60 km
time trial. The findings support previous research that
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concentrations (~10%) and carbohydrate delivery rates
may enhance exercise performance [22,24]. This should
be interpreted with a degree of caution for the end-user
based on total exercise duration. For events ranging from
2 to 6 hours, such findings may be applicable. However,
for shorter duration events, there is little evidence that
‘multiple transportable carbohydrates’ provide any ergo-
genic benefit over that of maltodextrin or glucose based
beverages. Indeed, for events < 90 minutes, water only
strategies may offer equally valid benefits [37]. Further-
more, as the duration exceeds 6 hours, beverage and
gastrointestinal tolerance may have a negative impact on
performance, indicating a potential need for lower dosing
and fluid delivery strategies [10,38].
In this study, both test beverages resulted in higher
CHOTOT compared with P during exercise undertaken
at 50% Wmax. As steady state exercise intensity was com-
parable across trials (for oxygen uptake, power output
and perceived exertion), the use of P resulted in a higher
rate of CHOENDO and FATTOT, which was expected. The
inclusion of the two test beverages resulted in lower
CHOENDO, potentially decreasing reliance on hepatic
glucose utilisation, and permitting glycogen sparing,
particularly in type I muscle fibres, during continuous
aerobic exercise. Indeed, as the use of carbohydrate bev-
erages has been shown to spare glycogen early into exer-
cise [39], this may provide a subtle benefit late into
exercise if CHOTOT is enhanced.
Whilst CHO sparing from endogenous sources was
apparent with both test beverages across all time points,
it was specifically noted that CHOTOT was 16.1% greater
with MD + F compared to MD in the final 30 minutes of
the oxidation trial. This differs from previous research
utilising similar dosing strategies of fructose: maltodex-
trin [11], which is surprising considering CHOEXO rates
during the same time frame were significantly increased
and comparable to values observed in the current study.
As there was a progressive increase in CHOEXO with
MD + F throughout the oxidation trial (with mean
CHOEXO of 1.27 g.min
-1 being significantly greater than
MD), this implies that intestinal saturation was not a
limiting factor at this dosage, as supported elsewhere
[5,11]. During the MD trial, CHOEXO was maintained
from 90 minutes indicating potential saturation of the
SGLT1 transporter mechanism. As there was no sig-
nificant difference in either average CHOEXO or carbo-
hydrate oxidation efficiency between the test beverages
prior to this, the use of combined sugar beverages
may be more applicable for events lasting longer than
90 minutes, supporting current recommendations [4].
It should also be noted that participants in this study
undertook the oxidation trial following an overnight fast.
Whilst this is not normal practice for trained athletescompeting, it has been shown that the influence of
low dietary carbohydrate availability prior to sustained
exercise has little impact on accumulated CHOEXO and
steady state performance [40] in the presence of CHO
beverages. However, more prolonged states of starvation
have been shown to reduce CHOEXO [41]. In the current
study, participants maintained their habitual diet which
was unlikely to significantly impact on CHOEXO.
Peak CHOEXO for MD+ F compared well with previous
research [5,8,11], with values reaching 1.45 ± 0.09 g.min-1,
35.5% greater than MD, by the end of the oxidation trial.
When lower ingestion rates of 0.8 g.min-1 have been
employed to replicate practices employed by athletes
(48 g.hr-1), peak CHOEXO were not significantly different
between glucose + fructose versus glucose only beverages
(0.56 v 0.58 g.min-1 respectively, [9]). Therefore, benefits
of combined sugar beverages, particularly for longer
duration events, are more likely with higher ingestion
rates >1.0 g.min-1. Interestingly, when higher ratios of
fructose to maltodextrin have been employed [12], it
has been suggested that peak CHOEXO may occur with
a 0.8 F: MD ratio compared to 0.5 or 1.25 ratios at in-
gestion rates of 1.8 g.min-1. However, as the relative
concentrations of the beverages employed were >10%,
CHOTOT was considerably lower than the current study,
and short duration performance gains observed [12] may
not be replicated with longer duration events.
In the current study, the ratio of F: MD was 0.54 deliv-
ered at an ingestion rate of 1.7 g.min-1 (based on prod-
uct analysis). This resulted in a higher CHOTOT than
previously observed with a 0.8 ratio [12], most likely
based on higher CHOEXO and lower beverage concentra-
tion, which may not have limited gastric emptying rates
or intestinal beverage delivery. It is unknown whether
peak CHOEXO during this study would have been greater
if the oxidation trial had been extended. However previ-
ous research has indicated a relative maintenance so
long as ingestion rates are maintained and tolerated [42].
The ingestion of a commercially available MD + F sports
drink used in this study supports the general contention
that the inclusion of fructose to a glucose/maltodextrin
beverage will involve both SGLT1 and GLUT5 transport
mechanisms leading to an increased rate of total carbo-
hydrate delivery across the intestinal lumen.
Although higher ingestion rates of 2.4 g.min-1 have been
previously employed, leading to higher peak CHOEXO
rates of 1.75 g.min-1 [7], it is likely that a higher beverage
concentration, or total fluid consumption, would have led
to progressive gastrointestinal disturbances within this
cohort based on subjective reporting of drink tolerance at
the end of the study. At the ingestion rates employed, it
was apparent that gastrointestinal issues were less evident
with MD+ F compared to MD, but also that relative toler-
ance was being reached by the end of the performance
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well-trained athletes, as supported elsewhere [7] and from
observations of world class triathletes in our laboratory in
which peak CHOEXO have exceeded 1.75 g.min
-1 with
CHO ingestion rates of 2.0 g.min-1. Whether this indicates
a training adaptation or tolerance to beverage consump-
tion, or full saturation of SGLT1 and GLUT5 is unknown.
More likely, as trained endurance athletes are encouraged
to consume high carbohydrate diets to facilitate recovery
and repetitive training bouts, higher CHOEXO may be the
result of high carbohydrate availability, irrespective of total
muscle glycogen and GLUT4 expression [40].
An important finding from the study was that plasma
2H2O enrichment was significantly enhanced with the
inclusion of the MD + F formula, and statistically no dif-
ferent to P in the last 30 minutes of the oxidation trial.
As plasma 2H2O enrichment has been used elsewhere as
a semi-quantitative method [14,16], the finding indicates
that MD + F did not restrict fluid delivery. However,
findings for the MD beverage were significantly lower
than P at all timepoints. The most likely explanation is
that the ingestion of MD + F resulted in higher overall
CHOTOT and CHOEXO, particularly in the final 30 mi-
nutes of the oxidation trial. As saturation of the SGLT1
transporter may have occurred with MD, fluid uptake
across of the intestinal lumen may have been restricted.
The inclusion of fructose, however, may have prevented
complete intestinal SGLT1 saturation, hence allowing
continued fluid uptake.
Our results are comparable to previous research
[8,14,16], although plasma 2H2O enrichment values were
deemed higher in the current study where an MD + F
beverage was used. In previous studies, increasing bever-
age concentration above 6% resulted in reduced fluid
delivery based on a glucose only beverage [14]. Whilst
this may, in part, explain findings for the MD beverage,
it would appear that the combined use of MD + F at a
10% concentration did not restrict fluid delivery. During
events lasting longer than 2 hours where acute dehydra-
tion and carbohydrate depletion may limit sustained per-
formance, the use of a commercial MD + F beverage
may therefore support both high fluid delivery and
CHOEXO rates.
The use of combined carbohydrate beverages has been
shown to enhance exercise performance [22-24]. How-
ever, several of these studies did not assess CHOEXO to
support conclusions, or use commercial formulas more
applicable to the end user. Recent studies have indicated
that running performance may not be enhanced when
commercial beverages are employed [26]. In the current
study, 8 participants were unable to complete the 60 km
performance test, demonstrating the demanding nature
of the protocol. However, data for finishers of all trials
indicated that performance times and correspondingmean power outputs were significantly improved with
MD + F. Mean power output was 14.9% higher during
the MD + F trial compared to MD, and 13% higher
compared to P.
This observation compares with previous findings [22],
and may be a consequence of the higher CHOTOT and
CHOEXO at the end of the oxidation trial with MD + F.
Surprisingly mean power output was comparable be-
tween MD and P, which may indicate subjective percep-
tion of the test beverages and hence relative effort,
despite being randomly assigned to trial order. As all
participants were able to complete the performance trial
when consuming the test beverages, this demonstrates
the benefit of regularly consuming CHO during sus-
tained exercise. However, in a similar manner, perform-
ance times and mean power output was significantly
improved with MD + F compared with MD for all partic-
ipants (n = 14).
Whilst RPETOTAL and RPELEGS were comparable dur-
ing the performance test between conditions, it was
noted that mean blood glucose was higher with both
MD and MD + F compared to P. As power output was
higher in the MD + F condition, this correlated with
greater cardiovascular exertion despite similar perceived
effort. As both test drinks were matched for electrolyte
content, the buffering of endogenous acids is unlikely to
be a key mechanism explaining greater power output
with MD + F. Instead, higher CHOTOT and potential for
liver glycogen sparing with MD + F most likely explains
the significant increase in performance.
It is difficult to compare data from previous research
when different types of performance tests have been
employed. When shorter distance preloaded time trials
have been assessed, the use of glucose only beverages re-
sulted in a dose response effect, with 60 g.hr-1 leading to
a 10.7% increase in mean power over 20 km compared
to lower dosages [43]. However, as a limiting factor for
longer duration events may be CHOEXO, such results
may not extend to longer time trials when single carbo-
hydrate beverages are used. Furthermore, performance
times during sustained endurance events, such as Ironman
Triathlon, have been shown to correlate with higher total
CHO intakes ranging from 90–120 g.hr-1 [10], despite also
relating to a higher incidence of gastrointestinal responses.
In the current study, gastrointestinal responses did not
impede performance, although it was observed that
underlying responses were lower with MD+ F compared
to MD, similar to previous studies [5].
Where longer time trials (>100 km) have been per-
formed (without prior steady state exercise), findings are
mixed [44-46] both for low (0.62 g.min-1 [44]) and mod-
erate (1.10 g.min-1) ingestion rates [45]. As a higher
ingestion rate was employed in the current study, along
with greater beverage concentration, the high CHOTOT
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the improved performance during a 60 km time trial in
comparison to these studies. Additionally, if ergogenic
effects occur following peak CHOEXO, then overall trials
lasting <120 minutes may not be sufficient to observe
performance benefits from combined sugar beverages.
Conclusions
The use of a commercially available MD + F formula re-
sulted in greater increases in total and exogenous carbo-
hydrate oxidation rates during sustained steady state
exercise compared to an isoenergetic MD beverage, and
P. Additionally, the inclusion of fructose resulted in
matched fluid delivery compared with P, and resulted in
performance gains in direct comparison to MD. Athletes
undertaking sustained exercise greater than 2 hours
should consider strategies utilising combined carbohydrate
formulas to maximise carbohydrate and fluid delivery,
which may support enhanced exercise performance.
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